X

Bliss GVS Pharma Ltd Q1FY24; 48% fall in Profits.

Incorporated in 1984, Bliss GVS Pharma Limited is engaged in manufacturing, marketing, trading and export of pharmaceutical formulations in the form of suppositories, pessaries, capsules, tablets, and syrups.

Financial Results:

Bliss GVS Pharma Ltd reported Revenues for Q1FY24 of ₹160.00 Crores down from ₹189.00 Crore year on year, a fall of 15.34%.

Total Expenses for Q1FY24 of ₹142.00 Crores down from ₹157.00 Crores year on year, a fall of 9.55%.

Consolidated Net Profit of ₹14.00 Crores down 48.15% from ₹27.00 Crores in the same quarter of the previous year.

The Earnings per Share is ₹1.41, down 43.15% from ₹2.48 in the same quarter of the previous year.

*It is important to note that the way the results have been accounted for are slightly different than the ones the companies may choose to publish.

*The presented data is automatically generated. It may occasionally generate incorrect information.

Related Post